Symposium 6: Young people, artificial nutrition and transitional care the nutritional challenges of the young adult with cystic fibrosis: Transition

Proceedings of the Nutrition Society

Volumn 68, Issue 4, 2009, Pages 430-440

  Morton, Alison M ^a  

^a ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Cystic Fibrosis; Nutritional management; Nutritional support; Transition

Indexed keywords

ALPHA TOCOPHEROL; PANCREAS ENZYME; RETINOL; VITAMIN D; VITAMIN K GROUP; VITAMIN;

ADOLESCENCE; ARTIFICIAL FEEDING; COMORBIDITY; CONFERENCE PAPER; CYSTIC FIBROSIS; DIABETES MELLITUS; EATING DISORDER; ENTERIC FEEDING; ENZYME REPLACEMENT; HEALTH CARE DELIVERY; HOME CARE; HUMAN; LIVER DISEASE; MALABSORPTION; NUTRITIONAL SUPPORT; OSTEOPOROSIS; PANCREAS INSUFFICIENCY; RISK FACTOR; SURVIVAL TIME; VITAMIN SUPPLEMENTATION; ADULT; CALORIC INTAKE; CHILD; DIET THERAPY; FEMALE; MALE; MALNUTRITION; NUTRITIONAL REQUIREMENT; NUTRITIONAL STATUS; PATIENT CARE; REVIEW;

ADULT; CHILD; CONTINUITY OF PATIENT CARE; CYSTIC FIBROSIS; ENERGY INTAKE; ENTERAL NUTRITION; FEMALE; HUMANS; MALE; MALNUTRITION; NUTRITIONAL REQUIREMENTS; NUTRITIONAL STATUS; VITAMINS; YOUNG ADULT;

EID: 77949326284     PISSN: 00296651     EISSN: 14752719     Source Type: Journal    
DOI: 10.1017/S0029665109990176     Document Type: Conference Paper

References (137)

1. Dodge JA, Morison S, Lewis PA et al. (1997) Incidence, population and survival of cystic fibrosis in the UK, 1968-1995. Arch Dis Child 77, 493-496.
2. Dodge JA, Lewis PA, Stanton M et al. (2007) Cystic fibrosis mortality and survival in the UK: 1947-2003. Eur Respir J 29, 522-526.
3. Corey M, McLaughlin FJ, Williams M et al. (1988) A comparison of survival, growth and pulmonary function in patients with cystic fibrosis in Boston and Toronto. J Clin Epidemiol 41, 583-591.
4. Cystic Fibrosis Trust (2009) UK CF Registry Annual Data Report 2007. http://www.cftrust.org.uk/aboutcf/ publications/cfregistryreports/UK-CF- Registry-Annual- Data-Report-2007.pdf
5. Zielenski J & Tsui LC (1995) Cystic fibrosis: genotypic and phenotypic variations. Annu Rev Genet 29, 777-807.
6. The Hospital for Sick Children (2003) Cystic fibrosis mutation database - The Chromosome 7 Project. http:// www.genet.sickkids.on.ca/cftr/app
7. Dorfman R & Zielenski J (2006) Genotype-phenotype correlations in cystic fibrosis. In Progress in Respiratory Research. vol.34: Cystic Fibrosis in the 21st Century, pp. 61-68 [A Bush, EWFW Alton, JC Davies, U Griesenbach and A Jaffe, editors]. Basel, Switzerland: Karger AG.
8. Pencharz PB & Durie PR (2000) Pathogenesis of malnutrition in cystic fibrosis, and its treatment. Clin Nutr 19, 387-394.
9. Beker LT, Russek-Cohen E & Fink RJ (2001) Stature as a prognostic factor in cystic fibrosis survival. J Am Diet Assoc 101, 438-442.
10. Sharma R, Florea VG, Bolger AP et al. (2000) Wasting as an independent predictor of mortality in patients with cystic fibrosis. Thorax 56, 746-750.
11. Stern M, Wiedemann B, Wenzlaff P on behalf of the German Cystic Fibrosis Quality Assessment group (2008) From registry to quality management: the German Cystic Fibrosis Quality Assessment project 1995-2006. Eur Respir J 31, 29-35.
12. Steinkamp G & Wiedemann B on behalf of the German CFQA Group (2002) Relationship between nutritional status and lung function in cystic fibrosis: cross sectional and longitudinal analyses from the German Quality Assurance Project. Thorax 57, 596-601.
13. Zemel BS, Jawad AF, FitzSimmons S et al. (2000) Longitudinal relationship among growth, nutritional status, and pulmonary function in children with cystic fibrosis: analysis of the Cystic Fibrosis Foundation National CF Patient Registry. J Pediatr 137, 374-380.
14. Peterson ML, Jacobs DR Jr & Milla CE (2003) Longitudinal changes in growth parameters are correlated with changes in pulmonary function in children with cystic fibrosis. Pediatrics 112, 588-592.
15. Kastner-Cole D, Palmer CN, Ogston SA et al. (2005) Overweight and obesity in deltaF508 homozygous cystic fibrosis. J Pediatr 147, 402-404.
16. Pedreira CC, Robert RG, Dalton V et al. (2005) Association of body composition and lung function in children with cystic fibrosis. Pediatr Pulmonol 39, 276-280.
17. De Meer K, Gulmans VA & van der Laag J (1999) Peripheral muscle weakness and exercise capacity in children with cystic fibrosis. Am J Respir Crit Care Med 159, 748-754.
18. Bronstein MN, Sokol RJ, Abman SH et al. (1992) Pancreatic insufficiency, growth, and nutrition in infants identified by newborn screening as having cystic fibrosis. J Pediatr 120, 533-540.
19. Littlewood JM, Wolfe SP & Conway SP (2006) Diagnosis and treatment of intestinal malabsorption in cystic fibrosis. Pediatr Pulmomol 41, 35-49.
20. Robinson PJ, Smith AL & Sly PD (1990) Duodenal pH in cystic fibrosis and its relationship to fat malabsorption. Dig Dis Sci 35, 1299-1304.
21. Walters MP & Littlewood JM (1998) Faecal bile acid and dietary residue excretion in cystic fibrosis: age group variations. J Pediatr Gastroenterol Nutr 27, 296-300.
22. Roy CC, Weber AM, Morin CL et al. (1997) Abnormal biliary composition in cystic fibrosis. Effect of pancreatic enzymes. N Eng J Med 297, 1301-1305.
23. Sinaasappel M (1992) Relationship between intestinal function and chloride secretion in patients with cystic fibrosis. Netherlands J Med 41, 110-114.
24. Kalivianakis M, Minich DM, Bijleveld CM et al. (1999) Fat malabsorption in cystic fibrosis patients receiving enzyme replacement therapy is due to impaired intestinal uptake of long-chain fatty acids. Am J Clin Nutr 69, 127-134.
25. Laiho KM, Gavin J, Murphy JL et al. (2004) Maldigestion and malabsorption of 13C labelled tripalmitin in gastrostomy-fed patients with cystic fibrosis. Clin Nutr 23, 347-353.
26. Gregory PC (1996) Gastrointestinal pH, motility/transit and permeability in cystic fibrosis. J Pediatr Gastroenterol Nutr 23, 513-523.
27. Committee on Safety of Medicines (1995) Report of the Pancreatic Enzymes Working Party. London: H. M. Stationery Office.
28. Feranchak AP, Sontag MK, Wagener JS et al. (1999) Prospective long-term study of fat-soluble vitamin status in children with cystic fibrosis identified by newborn screening. J Pediatr 135, 601-610.
29. Cystic Fibrosis Trust Nutrition Working Group (2002) Nutritional Management of Cystic Fibrosis. London: Cystic Fibrosis Trust.
30. Sinaasappel M, Stern M, Littlewood J et al. (2002) Nutrition in patients with cystic fibrosis: a European Consensus. J Cyst Fibros 1, 51-75.
31. Christian P & West KP (1998) Interactions between zinc and vitamin A: An update. Am J Clin Nutr 68, 435s-441s.
32. Durie PR (1994) Vitamin K and the management of the patient with cystic fibrosis. Can Med Assoc J 151, 933-936.
33. Rashid M, Durie P, Andrew M et al. (1999) Prevalence of vitamin K deficiency in cystic fibrosis. Am J Clin Nutr 70, 378-382.
34. De Montalembert M, Lenoir G, Saint-Raymond A et al. (1992) Increased PIVKA-II concentrations in patients with cystic fibrosis. J Clin Path 45, 180-181.
35. Alexander GD, Marcus MS & Green CG (1998) Subclinical vitamin K deficiency in cystic fibrosis. Pediatr Pulmonol Suppl 17, 353.
36. Rayner RJ, Tyrell JC, Hiller EJ et al. (1989) Night blindness and conjunctival xerosis due to vitamin A deficiency in patients with cystic fibrosis. Arch Dis Child 64, 1151-1156.
37. Campbell DC, Tole DM, Doran RML et al. (1998) Vitamin A deficiency in cystic fibrosis resulting in severe xerophthalmia. J Hum Nutr Diet 11, 529-532.
38. Greer RM, Buntain HM, Lewindon PJ et al. (2004) Vitamin A levels in patients with cystic fibrosis are influenced by the inflammatory response. J Cyst Fibros 3, 143-149.
39. Aird FK, Greene SA, Ogston SA et al. (2006) Vitamin A and lung function in CF. J Cyst Fibros 5, 129-131.
40. Graham-Maar RC, Schall JI, Stettler N et al. (2006) Elevated vitamin A intake and serum retinol in preadolescent children with cystic fibrosis. Am J Clin Nutr 84, 174-182.
41. Stephenson A, Brotherwood M, Robert R et al. (2005) Increased vitamin A and E levels in adult cystic fibrosis patients after lung transplantation. Transplantation 79, 613-615.
42. Lark RK, Lester GE, Ontjes DA et al. (2001) Diminished and erratic absorption of ergocalciferol in adult cystic fibrosis patients. Am J Clin Nutr 73, 602-606.
43. Coppenhaver D, Kueppers F, Schidlow D et al. (1981) Serum concentrations of vitamin D binding protein (group specific component) in cystic fibrosis. Hum Genet 57, 399-403.
44. Scott J, Elias E, Moult PJA et al. (1977) Rickets in adult cystic fibrosis with myopathy, pancreatic insufficiency and proximal tubular dysfunction. Am J Med 63, 488-492.
45. Friedman HZ, Ingman CB & Favus MJ (1985) Vitamin D metabolism and osteomalacia in cystic fibrosis. Gastroenterology 88, 808-813.
46. Elkin SL, Fairney A, Burnett S et al. (2001) Vertebral deformities and low bone mineral density in adults with cystic fibrosis: a cross sectional study. Osteoporos Int 12, 366-372.
47. Stephenson A, Brotherwood M, Robert R et al. (2007) Cholecalciferol significantly increases 25-hydroxyvitamin D concentrations in adults with cystic fibrosis. Am J Clin Nutr 85, 1307-1311.
48. Grey V, Atkinson S, Drury D et al. (2008) Prevalence of low bone mass and deficiencies of vitamins D and K in pediatric patients with cystic fibrosis from 3 Canadian centers. Pediatrics 122, 1014-1020.
49. Conway SP, Oldroyd B, Brownlee KG et al. (2008) A cross-sectional study of bone mineral density in children and adolescents attending a Cystic Fibrosis Centre. J Cyst Fibros 7, 469-476.
50. Green D, Carson K, Leonard A et al. (2008) Current treatment recommendations for correcting vitamin D deficiency in pediatric patients with CF are inadequate. J Pediatr 153, 554-559.
51. Sermet-Gaudelus I, Souberbielle JC, Ruiz JC et al. (2007) Low bone mineral density in young children with cystic fibrosis. Am J Crit Care Med 175, 951-957.
52. Wolfenden LL, Judd SE, Shah R et al. (2008) Vitamin D and bone health in adults with cystic fibrosis. Clin Endocrinol 69, 374-381.
53. Bischoff-Ferrari HA, Giovannucci E, Willett WC et al. (2006) Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr 84, 18-28.
54. Aris RM, Merkel PA, Bachrach LK et al. (2005) Guide to bone health and disease in cystic fibrosis. J Clin Endocrinol Metab 90, 1888-1896.
55. Cystic Fibrosis Trust Bone Mineralisation Working Group (2007) Bone Mineralisation in Cystic Fibrosis. 1st ed. London: Cystic Fibrosis Trust.
56. Promislow JH, Goodman-Gruen D, Slymen DJ et al. (2002) Retinol intake and bone mineral density in the elderly: the Rancho Bernado Study. J Bone Miner Res 17, 1349-1358.
57. Willison HJ, Muller DP, Matthews S et al. (1985) A study of the relationship between neurological function and serum vitamin E concentrations in patients with cystic fibrosis. J Neurol Neurosurg Psychiatry 48, 1097-1102.
58. Kelleher J (1987) Laboratory measurement of nutrition in cystic fibrosis. J R Soc Med 80, 25-29.
59. Koscik RL, Lai HJ, Laxova A et al. (2005) Preventing early, prolonged vitamin E deficiency: An opportunity for better cognitive outcomes via early diagnosis through neonatal screening. J Pediatr 147, S51-S56.
60. Huang SH, Schall JI, Zemel BS et al. (2006) Vitamin E status in children with cystic fibrosis and pancreatic insufficiency. J Pediatr 148, 556-559.
61. Conway SP, Wolfe SP, Brownlee KG et al. (2005) Vitamin K status among children with cystic fibrosis and its relationship to bone mineral density and bone turnover. Pediatrics 115, 1325-1331.
62. Nicolaidou P, Stavrinadis I, Loukou I et al. (2006) The effect of vitamin K supplementation on biochemical markers of bone formation in children and adolescents with cystic fibrosis. Eur J Pediatr 165, 540-545.
63. Maqbool A & Stallings VA (2008) Update on fat-soluble vitamins in cystic fibrosis. Curr Opin Pulm Med 14, 574-581.
64. Cystic Fibrosis Trust Clinical Standards and Accreditation Group (2001) Standards for the Clinical Care of Children and Adults with Cystic Fibrosis in the UK. London: Cystic Fibrosis Trust.
65. Kerem E, Conway S, Elborn S et al. (2005) Standards of care for patients with cystic fibrosis: a European consensus. J Cyst Fibros 4, 7-26.
66. Skypala IJ, Ashworth FA, Hodson ME et al. (1998) Oral nutritional supplements promote significant weight gain in cystic fibrosis patients. J Hum Nutr Diet 11, 95-104.
67. White H, Morton AM, Peckham DG et al. (2004) Dietary intakes in adult patients with cystic fibrosis - do they achieve guidelines? J Cyst Fibros 3, 1-7.
68. Poustie VJ, Russell JE, Watling RM et al. (2006) Oral protein energy supplements for children with cystic fibrosis: CALICO multicentre randomised controlled trial. Br Med J 332, 632-636.
69. Smyth R & Walters S (2007) Oral calorie supplements for cystic fibrosis. Cochrane Database of Systematic Reviews 2009, issue 2, CD000406. http://mrw.interscience.wiley. com/cochrane/clsyrev/articles/CD000406/frame/html
70. Conway SP, Morton A & Wolfe S (2008). Enteral tube feeding for cystic fibrosis. Cochrane Database of Systematic Reviews 2008, issue 2, CD001198. http://mrw.interscience. wiley.com/cochrane/clsyrev/articles/CD001198/frame/html
71. Jelalian E, Stark LJ, Reynolds L et al. (1998) Nutritional intervention for weight gain in cystic fibrosis: a meta analysis. J Pediatr 13, 486-492.
72. Rosenfeld M, Casey S, Pepe M et al. (1999) Nutritional effects of long-term gastrostomy feedings in children with cystic fibrosis. J Am Diet Assoc 99, 191-194.
73. Efrati O, Mei-Zahav M, Rivlin J et al. (2006) Long term rehabilitation by gastrostomy in Israeli patients with cystic fibrosis: clinical outcome in advanced pulmonary disease. J Pediatr Gastroenterol Nutr 42, 222-228.
74. Walker SA & Gozal D (1998) Pulmonary function correlates in the prediction of long-term weight gain in cystic fibrosis patients with gastrostomy tube feedings. J Pediatr Gastroenterol Nutr 27, 53-56.
75. Williams SG, Ashworth F, McAlweenie A et al. (1999) Percutaneous endoscopic gastrostomy feeding in patients with cystic fibrosis. Gut 44, 87-91.
76. Steinkamp G & Von Der Hardt H (1994) Improvement of nutritional status and lung function after long-term nocturnal gastrostomy feedings in cystic fibrosis. J Pediatr 124, 244-249.
77. Gunnell S, Christensen NK, McDonald C et al. (2005) Attitudes toward percutaneous endoscopic gastrostomy placement in cystic fibrosis patients. J Pediatr Gastroenterol Nutr 40, 334-338.
78. Oliver MR, Heine RG, Hang Ng C et al. (2004) Factors affecting clinical outcome in gastrostomy-fed children with cystic fibrosis. Pediatr Pulmonol 37, 324-329.
79. Van Biervliet S, De Waele K, Van Winckel M et al. (2004) Percutaneous endoscopic gastrostomy in cystic fibrosis: patient acceptance and effect of overnight tube feeding on nutritional status. Acta Gastroenterol Belg 67, 241-244.
80. Abbott J, Morton AM, Musson H et al. (2007) Nutritional status, perceived body image and eating behaviours in adults with cystic fibrosis. Clin Nutr 26, 91-99.
81. Smith DL, Clarke JM & Stableforth DE (1994) A nocturnal nasogastric feeding programme in cystic fibrosis adults. J Hum Nutr Diet 7, 257-262.
82. Kane RE & Black P (1989) Glucose intolerance with low-, medium-, and high-carbohydrate formulas during night time enteral feedings in cystic fibrosis patients. J Pediatr Gastroenterol Nutr 8, 321-326.
83. Cystic Fibrosis Foundation (2003) Patient Registry 2002 Annual Report. Bethesda, MD: Cystic Fibrosis Foundation.
84. Moran A, Hardin D, Rodman D et al. (1999) Diagnosis, screening and management of cystic fibrosis related diabetes mellitus: a consensus conference report. Diabetes Res Clin Pract 45, 61-73.
85. O'Riordan SMP, Robinson PD, Donaghue KC et al. (2008) Management of cystic fibrosis related diabetes. Pediatr Diabetes 9, 338-344.
86. Moran A, Doherty L, Wang X et al. (1998) Abnormal glucose metabolism in cystic fibrosis. J Pediatr 133, 10-17.
87. Lanng S, Thorsteinsson B, Pociot F et al. (1993) Diabetes mellitus in cystic fibrosis: genetic and immunological markers. Acta Paediatr 82, 150-154.
88. Lanng S, Hansen A, Thorsteinsson B et al. (1995) Glucose tolerance in patients with cystic fibrosis: five year prospective study. Br Med J 311, 655-659.
89. Lanng S (1997) Glucose intolerance in cystic fibrosis. Dan Med Bull 44, 23-39.
90. Mueller-Brandes C, Holl RW, Nastoll M et al. (2005) New criteria for impaired fasting glucose and screening for diabetes in cystic fibrosis. Eur Respir J 25, 715-717.
91. Cystic Fibrosis Trust Diabetes Working Group (2004) Management of Cystic Fibrosis Related Diabetes Mellitus. London: Cystic Fibrosis Trust.
92. Hardin DS, LeBlanc A, Para L et al. (1999) Hepatic insulin resistance and defects in substrate utilisation in cystic fibrosis. Diabetes 48, 1082-1087.
93. Hardin DS, LeBlanc A, Marshall G et al. (2001) Mechanisms of insulin resistance in cystic fibrosis. Am J Physiol Endocrinol Metab 281, E1022-E1028.
94. Rosenecker J, Eichler I, Kuhn L et al. (1995) Genetic determinants of diabetes mellitus in patients with cystic fibrosis. J Pediatr 127, 441-443.
95. Adler AI, Gunn E, Haworth CS et al. (2007) Characteristics of adults with and without cystic fibrosis-related diabetes. Diabet Med 24, 1143-1148.
96. Adler AI, Shine BSF, Chamnan P et al. (2008) Genetic determinants and epidemiology of cystic fibrosis-related diabetes: results from a British cohort of children and adults. Diabetes Care 31, 1789-1794.
97. Marshall BC, Butler SM, Stoddard M et al. (2005) Epidemiology of cystic-fibrosis related diabetes. J Pediatr 146, 681-687.
98. Ahmed N, Corey M, Forstner G et al. (2003) Molecular consequences of cystic fibrosis transmembrane regulator (CFTR) gene mutations in the exocrine pancreas. Gut 52, 1159-1164.
99. White H, Pollard K, Etherington C et al. (2009) Nutritional decline in cystic fibrosis related diabetes: The effect of intensive nutritional intervention. J Cyst Fibros 8, 179-185.
100. Hadjiliadis D, Madill J, Chaparro C et al. (2005) Incidence and prevalence of diabetes mellitus in patients with cystic fibrosis undergoing lung transplantation before and after lung transplantation. Clin Transplant 19, 773-778.
101. Navas de Solis MS, Merino Torres JF, Mascarell Martinez I et al. (2007) Lung transplantation and the development of diabetes mellitus in adult patients with cystic fibrosis. Arch Bronconeumol 43, 86-91.
102. Koch C, Rainisio M, Madessani U et al. (2001) Presence of cystic fibrosis related diabetes mellitus is tightly linked to poor lung function in patients with cystic fibrosis: data from the European Epidemiologic Registry of Cystic Fibrosis. Pediatr Pulmonol 32, 343-350.
103. Lanng S, Thorsteinsson B, Nerup J et al. (1992) Influence of the development of diabetes mellitus on clinical status in patients with cystic fibrosis. Eur J Pediatr 151, 2141-2144.
104. Milla CE, Billings J & Moran A (2005) Diabetes is associated with dramatically decreased survival in female but not male subjects with cystic fibrosis. Diabetes Care 28, 2141-2144.
105. Sims EJ, Green MW & Mehta A (2005) Decreased lung function in female but not male subjects with established cystic fibrosis-related diabetes. Diabetes Care 28, 1581-1587.
106. Costa M, Potvin S, Hammana I et al. (2007) Increased glucose excursion in cystic fibrosis and its association with a worse clinical status. J Cyst Fibros 6, 376-383.
107. Lanng S, Thorsteinsson B, Lund-Andersen C et al. (1994) Diabetes mellitus in Danish cystic fibrosis patients: prevalence and late complications. Acta Paediatr 83, 72-77.
108. Yung B, Landers A, Mathalone B et al. (1998) Diabetic retinopathy in adult patients with cystic fibrosis related diabetes. Respir Med 92, 871-872.
109. Schwarzenberg SJ, Thomas W, Olsen TW et al. (2007) Microvascular complications in cystic fibrosis related diabetes. Diabetes Care 30, 1056-1061.
110. Andersen HU, Lanng S, Pressler T et al. (2006) Cystic fibrosis-related diabetes: The prevalence of microvascular diabetes complications. Diabetes Care 29, 2660-2663.
111. Van den Berg JM, Morton AM, Kok SW et al. (2008) Microvascular complications in patients with cystic fibrosisrelated diabetes (CFRD). J Cyst Fibros 7, 515-519.
112. Wilson DC, Kalnins D, Stewart C et al. (2000) Challenges in the dietary management of cystic fibrosis related diabetes mellitus. Clin Nutr 19, 87-93.
113. Haworth CS, Selby PL, Webb AK et al. (1999) Low bone mineral density in adults with cystic fibrosis. Thorax 54, 961-967.
114. Conway SP, Morton AM, Oldroyd B et al. (2000) Osteoporosis and osteopenia in adults and adolescents with cystic fibrosis: prevalence and associated factors. Thorax 55, 798-804.
115. Shane E, Silverberg SJ, Donovan D et al. (1996) Osteoporosis in lung transplantation candidates with end-stage pulmonary disease. Am J Med 101, 262-269.
116. Aris RM, Renner JB, Winders AD et al. (1998) Increased risk of fractures and severe kyphosis: Sequelae of living into adulthood with cystic fibrosis. Ann Intern Med 128, 186-193.
117. Douros K, Loukou I, Nicolaidou P et al. (2008) Bone mass density and associated factors in cystic fibrosis patients of young age. J Paediatr Child Health 44, 681-685.
118. Bailey DA, McKay HA, Mirwald RL et al. (1999) A sixyear longitudinal study of the relationship of physical activity to bone mineral accrual in growing children: the University of Saskatchewan bone mineral accrual study. J Bone Miner Res 14, 1672-1679.
119. Cadogan J, Eastell R, Jones N et al. (1997) Milk intake and bone mineral acquisition in adolescent girls: Randomised, controlled intervention trial. Br Med J 315, 1255-1260.
120. Schulze KJ, O'Brien KO, Germain-Lee EL et al. (2003) Efficiency of calcium absorption is not compromised in clinically stable prepubertal and pubertal girls with cystic fibrosis. Am J Clin Nutr 78, 110-116.
121. Schulze KJ, Cutchins C, Rosenstein BJ et al. (2006) Calcium acquisition rates do not support age-appropriate gains in total body bone mineral content in prepuberty and late puberty in girls with cystic fibrosis. Osteoporos Int 17, 731-740.
122. Vermeer C (2004) Increased vitamin K intake may decrease bone loss. Osteoporos Rev 12, 11-14.
123. Stallings VA, Stark LJ, Robinson KA et al. (2008) Evidence-based practice recommendations for nutritionrelated management of children and adults with cystic fibrosis and pancreatic insufficiency: Results of a systematic review. J Am Diet Assoc 108, 832-839.
124. Vaisman N, Pencharz PB, Corey M et al. (1987) Energy expenditure of patients with cystic fibrosis. J Pediatr 111, 496-500.
125. Pencharz P, Hill R, Archibald E et al. (1984) Energy needs and nutritional rehabilitation in undernourished adolescents and young adult patients with cystic fibrosis. J Pediatr Gastroenterol Nutr 3, S147-S153
126. Jones J, Lawson ML, Daneman D et al. (2000) Eating disorders in adolescent females with and without type 1 diabetes: cross sectional study. Br Med J 320, 1563-1566.
127. Meltzer LJ, Johnson SB, Prine JM et al. (2001) Disordered eating, body mass and glycaemic control in adolescents with type 1 diabetes. Diabetes Care 24, 678-682.
128. Raymond NC, Chang PN, Crow SJ et al. (2000) Eating disorders in patients with cystic fibrosis. J Adolesc 23, 359-363.
129. Shearer JE & Bryon M (2004) The nature and prevalence of eating disorders and eating disturbance in adolescents with cystic fibrosis. J R Soc Med 97, 36-42.
130. Abbott J, Conway SP, Etherington C et al. (2000) Perceived body image and eating behavior in young adults with cystic fibrosis and their healthy peers. J Behav Med 23, 501-517.
131. Abbott J, Conway SP, Etherington C et al. (1998) Cystic fibrosis related diabetes, eating behaviours and body satisfaction. Pediatr Pulmonol Suppl 17, 395.
132. Department for Education and Skills (2004) The National Service Framework for Children, Young People and Maternity Services. Department of Health, London, UK.
133. Royal College of Nursing (2004) Adolescent Transition Care. London: Royal College of Nursing.
134. Conway SP (1998) Transition from paediatric to adult orientated care for adolescents with cystic fibrosis. Disabil Rehabil 20, 209-216.
135. Department for Children, Schools and Families (2008) Transition: Moving on Well. London: Department of Health.
136. Department for Education and Skills (2006) Transition: Getting it Right for Young People. London: Department of Health.
137. Conway SP, Brownlee KG, Peckham DG et al. (2008) Cystic Fibrosis in Children and Adults: The Leeds Method of Management, 7th ed. Leeds: Leeds Teaching Hospitals Trust.